论文信息 - Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer - 字舞流文

Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer

A. Tinker | Jubilee Brown | Susana Banerjee | V. Moreno | V. Samouëlian | A. Oaknin | C. Mathews | L. Gilbert | R. Sabatier | H. Danaee | E. Im | A. Gravina | Wei Guo | S. Banerjee | M. Barretina-Ginesta | C. Abdeddaim